Office of the Vice President for Research


Nervomatrix logo

Hyperstimulation device for treating patients with back and neck pain.

Nervomatrix was founded in 2007 by a group of healthcare professionals and engineers who developed Soleve®, its proprietary technology and made it available for patients and clinicians. Soleve®, an FDA cleared, and CE marked, medical device, is new modality for treating patients with back and neck pain. Following its market introduction in 2012, with over 11,000 patients treated in over 40 clinical centers, Soleve® Targeted Hyper-Stimulation technique, proves to be the most innovative and superior, drug-free modality for back and neck pain relief.

The company operates in the United States, Germany and other European countries through its fully owned subsidiaries. 


Kobi Benita, VP Global Sales & Marketing